首页> 外国专利> Bacterial vaccine that allows differentiation between infected and vaccinated animals, particularly pigs, comprises knock-out mutations in at least three genes, one encoding an immunogenic protein that serves as marker

Bacterial vaccine that allows differentiation between infected and vaccinated animals, particularly pigs, comprises knock-out mutations in at least three genes, one encoding an immunogenic protein that serves as marker

机译:允许在感染动物和接种疫苗的动物(尤其是猪)之间进行区分的细菌疫苗,至少在三个基因中包含敲除突变,一个基因编码一种用作标记的免疫原性蛋白质

摘要

Bacterial vaccine (A) for use in an animal, comprises a bacterial infective agent (B) having a knock-out mutation in each of at least three different chromosomal genes (I), where (I) encodes an immunogenic protein (IP), which serves as a marker, in (B). IP generates antibodies (Ab) that are not essential for protective immunity of the animal. Independent claims are included for the following: (1) method for preparing (A); (2) bacterium used in (A); (3) live or inactivated, negative-marker vaccines that include at least one (A); (4) diagnostic method for differentiating between infected animals; animals inoculated with (A) and/or animals both naturally infected and vaccinated; (5) immunogenic proteins (IP), synthesized from at least one (B) in a vaccine (A) that generates Ab, preferably not essential for a protective immune response; (6) nucleic acid (NA) that encodes IP, including at least one mutation for matching the specific codon usage of at least one expression host, particularly Actinobacillus pleuropneumoniae or Escherichia coli; (7) host cell containing the vector of (7); (8) preparation of recombinant IP, encoded by NA, by growing the cells of (8); and (9) recombinant IP prepared by method (9). ACTIVITY : Antibacterial. MECHANISM OF ACTION : Vaccine.
机译:用于动物的细菌疫苗(A),包括在至少三个不同的染色体基因(I)的每一个中均具有敲除突变的细菌感染剂(B),其中(I)编码免疫原性蛋白质(IP),在(B)中用作标记。 IP产生的抗体(Ab)对动物的保护性免疫不是必需的。包括以下方面的独立权利要求:(1)制备方法(A); (2)(A)中使用的细菌; (3)活疫苗或灭活的阴性标记疫苗,其中至少包括一种(A); (4)区分感染动物的诊断方法;接种(A)的动物和/或自然感染和接种过的动物; (5)免疫原性蛋白质(IP),其由产生Ab的疫苗(A)中的至少一种(B)合成,优选地对于保护性免疫应答不是必需的; (6)编码IP的核酸(NA),其包括至少一种突变以匹配至少一种表达宿主,特别是胸膜肺炎放线杆菌或大肠杆菌的特定密码子使用; (7)含有(7)的载体的宿主细胞。 (8)通过使(8)的细胞生长,制备由NA编码的重组IP。 (9)通过方法(9)制备的重组IP。活动:抗菌。作用机理:疫苗。

著录项

相似文献

  • 专利
  • 外文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号